3/14
Health Sciences
Survey shows patients with disabilities less likely to feel respect from doctors
A new Penn Medicine analysis shows that patients with disabilities were both less likely to feel respect from their doctors and less likely to feel their doctors explained things well.
Exploring the role of AI in palliative care and decision-making
Working with professors George Demiris and Connie Ulrich, Penn Nursing Ph.D. student Oonjee Oh is investigating the role of AI in end-of-life care from technological and ethical perspectives.
Innate immune training aggravates inflammatory bone loss
Researchers from the School of Dental Medicine and international collaborators from Germany have investigated the effects of training the innate immune system in experimental models of chronic inflammatory disease, periodontitis and arthritis.
One tiny dog’s outsized contribution to brain surgery
A terrier mix makes history as the first patient to undergo canine neurosurgery in a collaborative effort of specialists in human and veterinary medicine using cutting-edge augmented reality technology and infrared imaging.
Text message tool addresses ‘time toxicity’ for cancer patients
In pilot study from Penn Medicine, patients saved over an hour of time at every treatment visit using digital technology.
New mRNA therapy could repair damaged lungs
Penn researchers have designed an organ-specific mRNA and lipid nanoparticle therapy which could lead to new targeted treatments for damaged organs.
Getting to the root of root canals
Penn researchers use iron oxide nanozymes to treat infections during root canals with fewer adverse effects than clinical gold standard while also promoting tissue healing.
Increased cancer risk for kidney transplant recipients linked to Epstein-Barr virus
Researchers suggest changes in kidney transplant care and monitoring.
With hemophilia B, a lifetime of worry eased with one infusion
The first Penn Medicine patient to receive an FDA-approved new gene therapy for hemophilia B can now stop regular prophylactic clotting factor injections.
Pursuing vaccines to stop celiac disease
Scientists at Penn’s Institute for RNA Innovation are using messenger RNA to stop the immune response that triggers celiac disease symptoms.
In the News
Children, teens face 25% higher risk for adverse GI outcomes after COVID-19 infection
According to a study by Ph.D. student Dazheng Zhang of the Perelman School of Medicine and colleagues, children and adolescents experienced increased risk for gastrointestinal symptoms and disorders after COVID-19 infections.
FULL STORY →
Pennsylvania doctors reflect on COVID-19 pandemic 5 years later
Raina Merchant of the Perelman School of Medicine says that Penn Medicine had to be nimble during the COVID-19 pandemic to respond to many changes in information and optimize care for patients.
FULL STORY →
Is This Viral Trend Really the Ultimate Cure for Bloat?
Anish A. Sheth of the Perelman School of Medicine says there’s no medical evidence that topical castor oil has any medically therapeutic benefits.
FULL STORY →
Mutated DNA restored to normal in gene therapy advance
Kiran Musunuru of the Perelman School of Medicine says that a new infusion offers the hope of precisely treating other genetic diseases by fixing mutations, an alternative to current gene therapies.
FULL STORY →
Consider cost-effectiveness of treatment when managing glaucoma
Lama Al-Aswad of the Perelman School of Medicine says that glaucoma should be diagnosed early to decrease the cost to health care, help patients, and prevent blindness.
FULL STORY →